drugset / Trial / NCT02477397
Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD
RandomizedParallel-groupOpen-labelTreatment
Summary
Study to investigate the effects of symptom-driven maintenance and reliever therapy in COPD.
Timeline
- Start
- 2015-05-01
- Primary completion
- 2019-06-15
- Completion
- 2019-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 160 ug | Inhaled |
| Comparator | Fluticasone | Other / unclassified | 500 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 4.5 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 50 ug | Inhaled |
| Comparator | Salbutamol | Unknown | 100 ug | Inhaled |